Clinical Trials on Infections, Bacterial

Total 66542 results

Shanghai Zhongshan Hospital

Recruiting

Tetracycline Versus Doxycycline for HP Rescue Therapy

Helicobacter Pylori Infection

China
University of Aarhus

Recruiting

Fecal Microbiota Transplantation (FMT) for Clostridium Difficile (CEFTA)

Clostridium Difficile Infection

Denmark
TenNor Therapeutics Inc.

Completed

The Safety and Tolerability, Pharmacokinetics of TNP-2092 Capsules in Combination With Rabeprazole Sodium Enteric-coated Tablets

Helicobacter Pylori Infection

China
NYU Langone Health
National Institute on Minority Health and Health Disparities (NIMHD)

Completed

Patient-Centered Cancer Prevention In Chinese Americans

H. Pylori Infection

United States
TenNor Therapeutics (Suzhou) Limited

Completed

Efficacy and Safety After Multiple Doses of TNP-2198 Capsules, Rabeprazole Sodium Enteric-coated Tablets and Amoxicillin Capsules in Helicobacter Pylori Infected-positive Participants

Helicobacter Pylori Infection

China
TenNor Therapeutics (Suzhou) Limited

Completed

A Study to Evaluate Preliminary Helicobacter Pylori Eradication After Multiple Doses of TNP-2198 Capsules Combined With Rabeprazole Sodium Enteric-coated Tablets, or Rabeprazole Sodium Enteric-coated Tablets and Amoxicillin Capsules

Helicobacter Pylori Infection

China
NorthShore University HealthSystem

Terminated

FMT Versus Antimicrobials for Initial Treatment of Recurrent CDI

Clostridium Difficile Infection

United States
Mackay Memorial Hospital

Completed

Intraluminal Mono-antibiotic Therapy for Helicobacter Pylori Infection - A Comparison of Levofloxacin Powder and Levofloxacin Solution

Helicobacter Pylori Infection

Taiwan
Chuncheon Sacred Heart Hospital
Hallym University Medical Center

Completed

Helicobacter Pylori Eradication Rates of Bismuth-containing Quadruple Therapy vs Modified Quadruple Therapy in Korea

Helicobacter Pylori Infection

Korea, Republic of
Seoul National University Bundang Hospital

Completed

The Diagnostic Validity of the Urea Breath Test

Helicobacter Pylori Infection

Korea, Republic of
Mackay Memorial Hospital

Completed

Intraluminal Amoxicillin Powder Monotherapy for Helicobacter Pylori Infection

Helicobacter Pylori Infection

Taiwan
Queen's University
The Physicians' Services Incorporated Foundation

Terminated

Harnessing the Healthy Gut Microbiota to Cure Patients With Recurrent C. Difficile Infection

Clostridium Difficile Infection

Canada
Shanghai Jiao Tong University School of Medicine

Unknown

Analysis of the Impact of Helicobacter Pylori on Salivary Microbiome in Adults

Helicobacter Pylori Infection

China
Simon M. Cutting

Terminated

Oral Vaccination Against Clostridium Difficile Infection (CDVAX)

Clostridium Difficile Infection
Novartis Vaccines

Completed

Efficacy and Safety of an H.Pylori Vaccine in H.Pylori-Negative Adults

Helicobacter Pylori Infection

Germany
Forest Laboratories

Withdrawn

Safety, Efficacy of Pylera BID Dosing in Eradication of H. Pylori

Helicobacter Pylori Infection

United States, Canada
Oxford University Clinical Research Unit, Vietnam
National Hospital for Tropical Diseases, Hanoi, Vietnam

Completed

Human Suis and Pig Diseases in Northern Vietnam

Streptococcus Suis Infection

Vietnam
Jinling Hospital, China

Unknown

Freeze-dried, Capsulized FMT for RCDI

Clostridium Difficile Infection

China
Incheon St.Mary's Hospital

Unknown

Comparison of the Eradications Rates of Sequential Therapy Versus Concomitant Therapy

Helicobacter Pylori Infection

Korea, Republic of
The Miriam Hospital

Unknown

Gut Microbiota Changes After Fecal Microbiota Transplantation

Clostridium Difficile Infection

United States
Fundación Pública Andaluza para la gestión de la...
Hospital Son Espases; Hospital Universitario Virgen Macarena; Hospital Son Llatzer and other collaborators

Completed

Piperacillin-Tazobactam Continuous Versus Intermittent Infusion for Pseudomonas Aeruginosa (PiperTazo)

Pseudomonas Aeruginosa Infection

Spain
Washington University School of Medicine
Centers for Disease Control and Prevention

Withdrawn

Fidaxomicin to Prevent Clostridium Difficile Colonization

Clostridium Difficile Infection

United States
Nanjing First Hospital, Nanjing Medical University

Not yet recruiting

Banxiaxiexin Decoction Combined With Vonoprazan-Amoxicillin Dual Therapy in H.Pylori Eradication

Helicobacter Pylori Infection

China
Ain Shams University

Recruiting

Efficacy and Safety of Black Seed Oil With Vonoprazan Based Triple Therapy in Treatment of Helicobacter Pylori

Helicobacter Pylori Infection

Egypt
Shanghai Jiao Tong University School of Medicine

Recruiting

Rescue Therapy for Helicobacter Pylori Infection

Helicobacter Pylori Infection

China
Yanqing Li
The Affiliated Hospital of Qingdao University; The Second Affiliated Hospital... and other collaborators

Recruiting

Comparison of Two Dual Therapies in the First-line Treatment of Helicobacter Pylori Infection （SHARE2301）

Helicobacter Pylori Infection

China
Shanghai East Hospital

Not yet recruiting

Vonoprazan-containing Triple Therapy Versus Empiric Bismuth Quadruple Therapy for First-line Helicobacter Pylori Treatment: a Randomized Clinical Trial

Helicobacter Pylori Infection

China
Shandong University
Linyi People's Hospital; Weifang Medical University

Not yet recruiting

The Efficacy of 10-day or 14-day Course of Bismuth-containing Quadruple Therapy:A Randomized Clinical Trial

Helicobacter Pylori Infection

China
Tel-Aviv Sourasky Medical Center
Weizmann Institute of Science

Recruiting

Auto Fecal Microbial Transplant Post Helicobacter Pylori Antibiotic Therapy

Helicobacter Pylori Infection

Israel
Xiuli Zuo

Not yet recruiting

Efficacy and Safety of 14-day Concomitant Therapy for Difficult-to-Treat Helicobacter Pylori Infection

Helicobacter Pylori Infection

China
Hospital Clinic of Barcelona

Recruiting

Arrangement of Collecting Venules for the Endoscopic Diagnosis of Helicobacter Pylori (MOTIVATION)

Helicobacter Pylori Infection

Spain, Belgium, Germany
Shandong University

Not yet recruiting

Efficacy and Safety of 14-day Concomitant Therapy for Helicobacter Pylori Infection

Helicobacter Pylori Infection

China
The First Affiliated Hospital of Nanchang University

Active, not recruiting

Helicobacter Pylori and Lacidophilin Tablets in Combination With Vonorazan Dual Therapy

Helicobacter Pylori Infection

China
Marin L. Schweizer, PhD
University of Pennsylvania; Washington University School of Medicine; University... and other collaborators

Active, not recruiting

Nasal Decolonization of Dialysis Patients Noses (PAINTS)

Staphylococcus Aureus Infection

United States
IRCCS Azienda Ospedaliero-Universitaria di Bologna

Completed

Sequential Therapy Versus Triple Therapy for Helicobacter Pylori Eradication: a Placebo-controlled Trial

Helicobacter Pylori Infection

Italy
Clinical Centre of Serbia

Unknown

Assesment of the Efficiency and Safety Helicobacter Pylori Therapy With or Without Saccharomyces Boulardii

Helicobacter Pylori Infection
Kangdong Sacred Heart Hospital

Unknown

Tailored Therapy for Clarithromycin-Resistant H. Pylori

Helicobacter Pylori Infection

Korea, Republic of
Sir Run Run Shaw Hospital

Unknown

Doxycycline- and Furazolidone-containing Quadruple Regimen is Superior of Tailored Therapy

Helicobacter Pylori Infection

China
Versailles Hospital
Institut Pasteur; Sanofi Pasteur, a Sanofi Company; Saint Antoine University...

Completed

Predictive Value of the Immune Response of the Host in Clostridium Difficile Infections (SERODIFF)

Clostridium Difficile Infection

France
Emergent BioSolutions
GlaxoSmithKline; Department of Health and Human Services; Centers for Disease...

Not yet recruiting

Clinical Benefit, Safety and PK of Raxibacumab in Subjects Exposed to Bacillus Anthracis

Infections, Bacterial
GlaxoSmithKline

Completed

To Assess Bioavailability, Food Effect and Pharmacokinetics of Gepotidacin Tablets: A Phase I, Single-Dose, 2 Part Study in Healthy Subjects.

Infections, Bacterial

United States
GlaxoSmithKline

Completed

Bioequivalence Study Between SKF101804 Cefixime 200 Milligram (mg)/5 Milliliter (mL) Suspension Versus Cefixime 200 mg/5 mL Suspension Reference Product in Healthy Adult Subjects Under Fasting Conditions

Infections, Bacterial

South Africa
GlaxoSmithKline

Completed

To Evaluate Safety, Tolerability, Pharmacokinetics, And Food Effect Of Single Doses Of GSK945237 In Healthy Subjects

Healthy Subjects | Infections, Bacterial

Australia
Theravance Biopharma

Completed

TD-1792 in Gram-positive Complicated Skin and Skin Structure Infection

Staphylococcal Skin Infection

United States
Cumberland Pharmaceuticals

Completed

Comparison of Telavancin and Vancomycin for Complicated Skin and Skin Structure Infections With a Focus on Methicillin-resistant Staphylococcus Aureus (ATLAS1)

Staphylococcal Skin Infection

United States
GlaxoSmithKline
Parexel

Completed

Bioequivalence Study Between GR37547 500 Milligrams (mg) Tablet Versus Ciprofloxacin 500 mg Tablet Reference Product in Healthy Adult Subjects

Infections, Bacterial

South Africa
GlaxoSmithKline

Withdrawn

A Bioequivalence Study of SKF101804 Cefixime Versus Cefixime Reference Formulation in Healthy Adults Under Fasting Conditions

Infections, Bacterial
GlaxoSmithKline

Completed

Bioavailability Of Flucloxacillin Capsules (250 mg and 500 mg)

Infections, Bacterial

Germany
GlaxoSmithKline

Completed

WEUKBRE5555: IMI PROTECT(Work Package 2): Liver Injury & Antibiotics

Infections, Bacterial
Melinta Therapeutics, Inc.

Completed

Relative Exposure and Safety Study of Kimyrsa in ABSSSI Patients

Acute Bacterial Skin and Skin Structure Infection

United States

Clinical Trials on Infections, Bacterial

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Congo

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations